abstract |
The present invention relates to aminotetraline derivatives of the formula (I) n nor a physiologically tolerated salt thereof.n n The invention relates to pharmaceutical compositions comprising such aminotetraline derivatives, and the use of such aminotetraline derivatives for therapeutic purposes. The aminotetraline derivatives are GlyT1 inhibitors. |